Loading...

Payer Scrutiny And Coverage Risks Will Limit Long-Term Precision Dermatology Potential

Published
13 Dec 25
Views
2
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
43.8%
7D
2.5%

Author's Valuation

US$3032.0% overvalued intrinsic discount

AnalystLowTarget Fair Value